Immediate Impact
54 standout
Citing Papers
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
Development of NK cell-based cancer immunotherapies through receptor engineering
2024 Standout
Works of Ke Cheng being referenced
CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
2023
Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ke Cheng | 142 | 74 | 80 | 126 | 43 | 375 | |
| Hüseyin Engin | 134 | 104 | 59 | 136 | 47 | 435 | |
| Kakil Ibrahim Rasul | 178 | 109 | 59 | 167 | 41 | 446 | |
| T Krechler | 127 | 36 | 103 | 129 | 29 | 432 | |
| Alex Y. C. Chang | 169 | 87 | 46 | 129 | 24 | 422 | |
| Hirotaka Takizawa | 91 | 49 | 61 | 158 | 35 | 455 | |
| Yoshitaka Seki | 172 | 108 | 62 | 107 | 38 | 413 | |
| H Ichihashi | 149 | 69 | 56 | 137 | 45 | 386 | |
| Xi Yang | 202 | 91 | 74 | 162 | 33 | 440 | |
| Kornelia Aigner | 168 | 79 | 70 | 156 | 28 | 379 | |
| Jie Yang | 117 | 82 | 85 | 137 | 42 | 358 |
All Works
Login with ORCID to disown or claim papers
Loading papers...